Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
General Hepatology
•
Hepatology
How do you approach the optimization and risk stratification of a cirrhotic patient who is undergoing extra-hepatic abdominal (or other) surgery?
Related Questions
How do you approach a patient who has incidentally found liver and renal cysts?
When giving albumin challenge, for acute kidney injury with suspected hepatorenal syndrome, do you administer a single dose daily or split the dose of albumin?
Is there a serum ammonium level for which you recommend initiation of dialysis in a patient with hepatic encephalopathy?
Do you always consider ADPCKD or ARPCKD in a patient who is incidentally found to have liver and renal cysts?
How would you approach the management of asymptomatic ALT and GGT elevation in an older adult patient with depression with psychosis and without history of hepatitis who recently had dose of quetiapine increased and new initiation of SNRI?
How do you utilize Cystatin-C as a marker of renal dysfunction in patients with chronic liver disease?
If you do not have easy access to shear wave elastography (aka Fibroscan), what do you recommend for non-invasive tests to determine if a MASLD patient has clinically significant portal hypertension and risk-stratify them?
What is your clinical approach to the evaluation of cytopenias in patients with end-stage liver disease?
What risk factors in a cirrhotic patient would predispose them to the development of sarcopenia and how do you address these risk factors?
How do you incorporate palliative care specialists into the care of patients with chronic liver disease, especially those who may not be transplant candidates?
